Unknown

Dataset Information

Asenapine versus placebo for schizophrenia.


ABSTRACT:

Background

Schizophrenia is a highly prevalent and chronic disorder that comprises a wide range of symptomatology. Asenapine is a recently developed atypical antipsychotic that is approved by the US Food and Drug Administration (FDA) for the treatment of schizophrenia.

Objectives

To determine the clinical effects of asenapine for adults with schizophrenia or other schizophrenia-like disorders by comparing it with placebo.

Search methods

We searched the Cochrane Schizophrenia Group's Trials Register (July 04, 2014) which is based on regular searches of MEDLINE, EMBASE, CINAHL, BIOSIS, AMED, PubMed, PsycINFO, and registries of clinical trials. There are no language, date, document type, or publication status limitation for inclusion of records into the register. We insp

SUBMITTER: Hay A 

PROVIDER: S-EPMC6464872 | biostudies-literature | 2015 Nov

REPOSITORIES: biostudies-literature